Gurugram, July 30: Artemis Hospital, Gurugram has achieved a significant milestone in advanced cancer and neurosurgical care with the successful completion of more than 2,500 CyberKnife radiosurgery procedures, reaffirming its position as one of India’s most experienced and trusted centres for robotic stereotactic radiosurgery. Under the leadership of Dr. Aditya Gupta, Chairman – Neurosurgery & CNS Radiosurgery and Co-Chief, CyberKnife Centre, the hospital has consistently expanded the scope of non-invasive treatment for patients with complex brain, spine, head & neck, lung, liver, prostate, and other difficult-to-treat tumors.
Artemis Hospital recently strengthened its radiosurgery capabilities with the installation of North India’s first M6 CyberKnife with VOLO™ technology, the latest generation robotic radiosurgery platform that significantly enhances treatment precision, speed, and patient comfort. The system incorporates advanced real-time image guidance, robotic beam delivery, and intelligent motion tracking, allowing clinicians to accurately target tumors that move with breathing or are located near critical organs. The VOLO optimization engine enables highly conformal treatment plans with reduced treatment time, improving both efficiency and patient experience.
Speaking on the occasion, Dr. Aditya Gupta, Chairman – Neurosurgery & CNS Radiosurgery and Co-Chief, CyberKnife Centre, Artemis Hospital, Gurugram said,
“Crossing the milestone of 2,500 CyberKnife procedures is a proud moment for our entire team and a reflection of the trust patients have placed in us. Every case represents a life that has benefited from precision medicine and multidisciplinary expertise. CyberKnife has revolutionized the way we manage several complex neurological and oncological conditions by enabling us to deliver sub-millimetre accuracy while preserving healthy surrounding tissue. For many patients, this technology has made it possible to avoid open surgery, prolonged hospitalization, and the complications associated with conventional treatment.”
Unlike conventional radiation therapy, CyberKnife does not require surgical incisions, head frames, or general anaesthesia in most cases. It delivers hundreds of finely focused radiation beams from multiple angles, automatically adjusting for even the slightest patient or tumor movement. This exceptional precision makes it particularly effective for treating tumors located in sensitive areas such as the brainstem, skull base, spine, and other anatomically challenging regions, while minimizing radiation exposure to healthy tissues.
Dr. Gupta further added,
“Our vision has always been to make world-class radiosurgery accessible to patients in India while continuously adopting the most advanced technologies available globally. The addition of the M6 CyberKnife with VOLO marks the beginning of a new chapter in precision radiation treatment. Combined with our team’s experience of over 2,500 successful procedures and thousands of complex brain surgeries, we are able to offer highly personalized treatment strategies that maximize effectiveness while preserving patients’ quality of life.”
Over the years, Artemis Hospital has successfully treated patients with both benign and malignant brain tumors, metastatic brain lesions, arteriovenous malformations, trigeminal neuralgia, spinal tumors, recurrent cancers, prostate cancer, lung tumors, liver tumors, pancreatic lesions, and other complex conditions using CyberKnife technology. The hospital’s multidisciplinary team carefully evaluates every patient to determine the most appropriate treatment approach, ensuring optimal outcomes through individualized care.
The completion of 2,500+ CyberKnife radiosurgeries is not merely a numerical achievement but a testament to Artemis Hospital’s sustained investment in advanced technology, clinical expertise, and evidence-based care. As the hospital continues to pioneer innovations in precision radiosurgery, it remains committed to delivering safer, more effective, and minimally invasive treatment options that improve outcomes and enhance the quality of life for patients across India and beyond.